Cargando…

Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users

OBJECTIVE: The aim of this study is to assess the prevalence of gastroprotection and identify the main factors that influence the taking of protective drugs by the adult population treated with non-steroidal anti-inflammatory drugs (NSAID). METHODS: This study was cross-sectional, conducted by inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shabani, Driton, Murtezani, Ardiana, Tahirbegolli, Bernard, Juniku-Shkololli, Argjira, Ibraimi, Zana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418831/
https://www.ncbi.nlm.nih.gov/pubmed/32832889
http://dx.doi.org/10.15386/mpr-1533
_version_ 1783569765603737600
author Shabani, Driton
Murtezani, Ardiana
Tahirbegolli, Bernard
Juniku-Shkololli, Argjira
Ibraimi, Zana
author_facet Shabani, Driton
Murtezani, Ardiana
Tahirbegolli, Bernard
Juniku-Shkololli, Argjira
Ibraimi, Zana
author_sort Shabani, Driton
collection PubMed
description OBJECTIVE: The aim of this study is to assess the prevalence of gastroprotection and identify the main factors that influence the taking of protective drugs by the adult population treated with non-steroidal anti-inflammatory drugs (NSAID). METHODS: This study was cross-sectional, conducted by including a contingent of 800 users of primary health care services (n=369, 46% males and n=431, 54% females). Included in the study were individuals of both genders aged 18+ who sought counselling or treatment during the three-month period. The data collection of this study was based on the completion of a structured questionnaire, which included questions related to the use of NSAIDs, the way these drugs were prescribed and administered and the simultaneous taking of gastroprotective drugs. RESULTS: The prevalence of the gastroprotective drugs use was higher among the elderly, individuals living in urban areas, those with higher education, those with daily use of NSAID, individuals receiving prescriptions from their own doctors, and those suffering from side effects from the use of NSAID, as well as subjects that had a longer duration of NSAID use. Diclofenac was the most prescribed NSAID. Gastric pain and dizziness were the most experienced side effects. CONCLUSION: This paper demonstrates the need to improve the quality of primary health care service through informing and educating patients regarding the need to take gastro-protective drugs for those at high risk of adverse effects manifested by the use of NSAIDs.
format Online
Article
Text
id pubmed-7418831
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-74188312020-08-20 Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users Shabani, Driton Murtezani, Ardiana Tahirbegolli, Bernard Juniku-Shkololli, Argjira Ibraimi, Zana Med Pharm Rep Original Research OBJECTIVE: The aim of this study is to assess the prevalence of gastroprotection and identify the main factors that influence the taking of protective drugs by the adult population treated with non-steroidal anti-inflammatory drugs (NSAID). METHODS: This study was cross-sectional, conducted by including a contingent of 800 users of primary health care services (n=369, 46% males and n=431, 54% females). Included in the study were individuals of both genders aged 18+ who sought counselling or treatment during the three-month period. The data collection of this study was based on the completion of a structured questionnaire, which included questions related to the use of NSAIDs, the way these drugs were prescribed and administered and the simultaneous taking of gastroprotective drugs. RESULTS: The prevalence of the gastroprotective drugs use was higher among the elderly, individuals living in urban areas, those with higher education, those with daily use of NSAID, individuals receiving prescriptions from their own doctors, and those suffering from side effects from the use of NSAID, as well as subjects that had a longer duration of NSAID use. Diclofenac was the most prescribed NSAID. Gastric pain and dizziness were the most experienced side effects. CONCLUSION: This paper demonstrates the need to improve the quality of primary health care service through informing and educating patients regarding the need to take gastro-protective drugs for those at high risk of adverse effects manifested by the use of NSAIDs. Iuliu Hatieganu University of Medicine and Pharmacy 2020-07 2020-07-22 /pmc/articles/PMC7418831/ /pubmed/32832889 http://dx.doi.org/10.15386/mpr-1533 Text en This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Research
Shabani, Driton
Murtezani, Ardiana
Tahirbegolli, Bernard
Juniku-Shkololli, Argjira
Ibraimi, Zana
Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users
title Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users
title_full Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users
title_fullStr Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users
title_full_unstemmed Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users
title_short Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users
title_sort non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418831/
https://www.ncbi.nlm.nih.gov/pubmed/32832889
http://dx.doi.org/10.15386/mpr-1533
work_keys_str_mv AT shabanidriton nonsteroidalantiinflammatorydrugsandgastroprotectioninprimaryhealthcareusers
AT murtezaniardiana nonsteroidalantiinflammatorydrugsandgastroprotectioninprimaryhealthcareusers
AT tahirbegollibernard nonsteroidalantiinflammatorydrugsandgastroprotectioninprimaryhealthcareusers
AT junikushkololliargjira nonsteroidalantiinflammatorydrugsandgastroprotectioninprimaryhealthcareusers
AT ibraimizana nonsteroidalantiinflammatorydrugsandgastroprotectioninprimaryhealthcareusers